United Kingdom · Venture startup

Who invested in NeoPhore

5 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$38Mraised across 5 rounds since 2021, from 6 sources

$334KRound$13MRound$7.0MRound$12MVenture$6.3MRound

Latest round: Round, $6.3MApr 2024
Biggest round: $13MRound · Jan 2022
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

202220232024

$334KRound$13MRound$7.0MRound$12MVenture$6.3MRound

First round: Round, $334K
Biggest round: $13M
Usual gap between rounds: 10 months

The rounds

Apr 2024
Round$6.3M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Jan 2024
Venture$12M2 new
- Innovate UK
- LIFTT
Shares issued, filed with Companies House (SH01); no report of this raise yet and 1 other
Dec 2022
Round$7.0M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Jan 2022
Round$13M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Sept 2021
Round$334K
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2021Round2022Round2022Venture2024Round2024

Innovate UK

LIFTT

Everyone who backed them

Innovate UKVC firm1round

LIFTTVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list NeoPhore as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.